New study below [1].
Preamble.
An interesting phenomenon of some Nordic vitamin D PCa studies is the U-shaped risk curve. Both, low & high levels of vitamin D are associated with increased PCa incidence.
One has to admire the audacity of the Nordic researcher who believes that the local population is ideal for vitamin D studies.
Who are the Nordic men with high levels of vitamin D?
At Nordic latitudes almost everyone has some degree of deficiency by the time that winter is over. Unless they supplement.
I used to know a man in Toronto who supplemented with 5,000 IUs & couldn't get out of the 'insufficiency' range during winter. Back then, most brands did not have high doses. Dr Myers reported that the only patients who were able to increase vitamin D levels, were those using the Life Extension high-dose product.
I always thought that Myers was slow to endorse supplements, but vitamin D was an early enthusiasm. And even 15+ years ago, vitamin D was a popular supplement among men with PCa.
So, who are the Nordic men with high D levels in the winter? I contend that they include some men with familal PCa. And also men with higher PSA levels. Generally, men who are concerned that they have a higher risk for PCa.
What we have is detetion bias, imo. Future PCa studies should exclude those who are supplementing because of a perceived PCa risk.
An important Swedish study that reported a U-shaped risk for PCa incidence, later reported lower PCa mortality at higher D levels.
An esteemed member of this group once said that if something does not help prevent PCa, it can't help you to survive it.
The Kuopio study.
Where the heck is Kuopio?
... Toronto is at latitude 43.6532°.
,,, Edinburgh is at latitude 55.9533°.
... Kuopio is at latitude 62.8980°.
"2578 middle-aged men belonging to the Kuopio Ischaemic Heart Disease Risk Factor Study" " were free of cancer at baseline, and the mean ... follow-up time was 23.3 ... years. During this period, 296 men had a PCA diagnosis, and 1448 men died without the PCA diagnosis. The absolute risk of developing PCA was highest in the highest 25(OH)D tertile (15%), whereas that of death was highest in the lowest 25(OH)D tertile (67%).
Here were the winter vitamin D levels in the Kuopio men (ng/mL):
... 1st tertile: 3.21 to 12.02 (average 9.62)
... 2nd tertile: to 17.23 (average 14,02)
... 3rd tertile: to 54.49 (average 30.45)
This looks pretty grim to those of us used to:
... deficiency: <20
... insufficiency: 20 to <32
... sufficiency: 32 & up
Anyway, for those of us with active PCa, I have yet to see a vitamin D survival curve that dips or even plateaus. There are usually not enough men at the higher levels to verify that & certainly not at latitude 63° N.
-Patrick
[1] pubmed.ncbi.nlm.nih.gov/352...
{Full: onlinelibrary.wiley.com/doi...
Andrologia
. 2022 Feb 28;e14410. doi: 10.1111/and.14410. Online ahead of print.
How competing risks affect the epidemiological relationship between vitamin D and prostate cancer incidence? A population-based study
Ari Voutilainen 1 , Jyrki K Virtanen 1 , Sari Hantunen 1 , Tarja Nurmi 1 , Petra Kokko 1 , Tomi-Pekka Tuomainen 1
Affiliations collapse
Affiliation
1 Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.
PMID: 35229338 DOI: 10.1111/and.14410
Abstract
We hypothesized that controversial results regarding the epidemiological relationship between circulating 25-hydroxyvitamin D, 25(OH)D, and risk of prostate cancer (PCA) incidence are partly due to competing risks. To test the hypothesis, we studied associations across 25(OH)D, PCA and death in 2578 middle-aged men belonging to the Kuopio Ischaemic Heart Disease Risk Factor Study. The men were free of cancer at baseline, and the mean (SD) follow-up time was 23.3 (9.1) years. During this period, 296 men had a PCA diagnosis, and 1448 men died without the PCA diagnosis. The absolute risk of developing PCA was highest in the highest 25(OH)D tertile (15%), whereas that of death was highest in the lowest 25(OH)D tertile (67%). A competing risk analysis showed that belonging to the highest 25(OH)D tertile increased the risk of PCA incidence and improved survival with the respective hazard ratios (HR) of 1.35 (95% CI = 1.07-1.70) and 0.79 (95% CI = 0.71-0.89). Adjusting for 10 covariates together with 25(OH)D did not significantly change the results, but the respective adjusted HRs for PCA and death were 1.20 and 0.87. To conclude, the competing risk analysis did not eliminate the direct relationship between 25(OH)D and PCA but rather strengthened it.
Keywords: cohort study; competing risk; incidence; prostate cancer; vitamin D.
© 2022 The Authors. Andrologia published by Wiley-VCH GmbH.